Phase I study of onapristone, a type I antiprogestin, in female patients with previously treated recurrent or metastatic progesterone receptor-expressing cancers.
Saved in:
| Title: | Phase I study of onapristone, a type I antiprogestin, in female patients with previously treated recurrent or metastatic progesterone receptor-expressing cancers. |
|---|---|
| Authors: | Cottu, Paul H.1 paul.cottu@curie.fr, Bonneterre, Jacques2, Varga, Andrea3, Campone, Mario4, Leary, Alexandra3, Floquet, Anne5, Berton-Rigaud, Dominique4, Sablin, Marie-Paule1, Lesoin, Anne2, Rezai, Keyvan6, Lokiec, François M.6, Lhomme, Catherine3, Bosq, Jacques3, Bexon, Alice S.7, Gilles, Erard M.8, Proniuk, Stefan9, Dieras, Veronique1, Jackson, David M.9, Zukiwski, Alexander9, Italiano, Antoine5 |
| Source: | PLoS ONE. 10/10/2018, Vol. 13 Issue 10, p1-16. 16p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 19326203 |
|---|---|
| DOI: | 10.1371/journal.pone.0204973 |
